会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明申请
    • DATA MIGRATION METHOD AND SYSTEM IN PEER-TO-PEER NETWORK
    • 数据迁移方法和系统在对等网络
    • WO2012136091A3
    • 2012-11-29
    • PCT/CN2012072071
    • 2012-03-07
    • ZTE CORPWANG WEITAO QUANJUN
    • WANG WEITAO QUANJUN
    • H04L29/08
    • H04L67/104
    • Disclosed is a data migration method in a peer-to-peer (P2P) network, the method comprising: when data migration is required, a source node requiring data migration compares the current data version of the data to be migrated with the data version corresponding to the destination node, determines incremental data and sends the incremental data to the destination node; the destination node recovers the latest version of the data according to the incremental data and the data stored in the destination node itself. Also disclosed is a data migration system in the P2P network. Using the method and system of the present invention can greatly reduce the data volume and migration time of data migrations in the P2P network, thus improving the data migration speed and reliability.
    • 本发明公开了一种点对点P2P网络中的数据迁移方法,该方法包括:当需要进行数据迁移时,需要进行数据迁移的源节点将待迁移数据的当前数据版本与对应的数据版本进行比较 到目的地节点,确定增量数据并将增量数据发送到目的地节点; 目的节点根据增量数据和存储在目的节点本身的数据恢复最新版本的数据。 还公开了P2P网络中的数据迁移系统。 采用本发明的方法和系统可以大大减少P2P网络中数据迁移的数据量和迁移时间,从而提高数据迁移的速度和可靠性。
    • 47. 发明申请
    • SYSTEMS AND METHODS FOR IDENTIFYING DRUG TARGETS USING BIOLOGICAL NETWORKS
    • 用于使用生物网络来识别药物目标的系统和方法
    • WO2011146619A9
    • 2012-02-16
    • PCT/US2011037001
    • 2011-05-18
    • UNIV CALIFORNIAWANG WEICHANG RUI
    • WANG WEICHANG RUI
    • G06F19/00
    • G06F19/707G06F19/12G06F19/18G06N5/02G06N7/005G06N99/005
    • Certain embodiments of the invention may include systems and methods for identifying drug targets using biological networks. According to an example embodiment of the invention, a method, is provided for predicting the effects of drug targets on treating a disease. The method can include constructing a structure of a. Bayesian network based at least in part on knowledge of drug inhibiting effects on a disease; associating a set of parameters with the constructed Bayesian network; determining values of a joint probability distribution of the Bayesian network via an automatic procedure; deriving a mean Bayesian network with one or more averaged parameters based at least in part on the joint probability values; and calculating a quantitative prediction based at least in part on the mean Bayesian network.
    • 本发明的某些实施例可以包括使用生物网络来识别药物靶标的系统和方法。 根据本发明的示例实施方式,提供了一种用于预测药物靶点对治疗疾病的作用的方法。 该方法可以包括构建a的结构。 贝叶斯网络至少部分基于对疾病的药物抑制作用的知识; 将一组参数与构建的贝叶斯网络相关联; 通过自动程序确定贝叶斯网络的联合概率分布的值; 至少部分地基于联合概率值来导出具有一个或多个平均参数的平均贝叶斯网络; 以及至少部分地基于平均贝叶斯网络来计算定量预测。
    • 50. 发明申请
    • CATALYTIC MATERIALS FOR FABRICATING NANOSTRUCTURES
    • 用于制造纳米结构的催化材料
    • WO2010093899A2
    • 2010-08-19
    • PCT/US2010024069
    • 2010-02-12
    • BABCOCK & WILCOX TECHNICAL SERUT BATTELLE LLCSEALS ROLAND DMENCHHOFER PAUL AHOWE JANE YWANG WEI
    • SEALS ROLAND DMENCHHOFER PAUL AHOWE JANE YWANG WEI
    • B01J23/74B01J23/00B01J35/02B82B1/00
    • B01J35/0013B01J21/08B01J23/74B01J23/745B01J31/0274B01J35/006B01J37/0072B01J37/033B01J37/18
    • Nano-catalysts that have utility for forming nanostructures and manufacturing nanomaterials are described. In some embodiments the nano-catalyst is formed from a powder-based substrate material and is some embodiments the nano-catalyst is formed from a solid-based substrate material. In some embodiments the substrate material may include metal, ceramic, or silicon or another metalloid. The nano-catalysts typically have metal nanoparticles disposed adjacent the surface of the substrate material. Methods of forming the nano-catalysts are disclosed. The methods typically include functionalizing the surface of the substrate material with a chelating agent, such as a chemical having dissociated carboxyl functional groups (-COO), that provides an enhanced affinity for metal ions. The functionalized substrate surface may then be exposed to a chemical solution that contains metal ions. The metal ions are then bound to the substrate material and may then be reduced, such as by a stream of gas that includes hydrogen, to form metal nanoparticles adjacent the surface of the substrate.
    • 描述了用于形成纳米结构和制造纳米材料的纳米催化剂。 在一些实施方式中,纳米催化剂由粉末基底材料形成,并且在一些实施方式中,纳米催化剂由固体基底材料形成。 在一些实施例中,衬底材料可以包括金属,陶瓷或硅或另一种准金属。 纳米催化剂通常具有邻近基底材料表面设置的金属纳米颗粒。 公开了形成纳米催化剂的方法。 所述方法通常包括用螯合剂(例如具有解离的羧基官能团(-COO)的化学品)对基底材料的表面进行官能化,所述螯合剂对金属离子提供增强的亲和力。 然后可以将官能化的基材表面暴露于含有金属离子的化学溶液。 然后将金属离子结合到基底材料上,然后可以例如通过包含氢气的气流将其还原,以在基底表面附近形成金属纳米颗粒。